Question 1

Does Zürcher Kantonalbank own ARWR stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Zürcher Kantonalbank holds 44,360 shares of ARWR (Arrowhead Pharmaceuticals), worth $3.6M.

Question 2

How many shares of ARWR does Zürcher Kantonalbank own?

Accepted Answer

As of its Q2 2026 13F, Zürcher Kantonalbank holds 44,360 shares of ARWR (Arrowhead Pharmaceuticals).

Question 3

What is Zürcher Kantonalbank's ARWR position worth?

Accepted Answer

As of its Q2 2026 13F, Zürcher Kantonalbank's ARWR position is worth $3.6M.

Question 4

Is Zürcher Kantonalbank buying or selling ARWR?

Accepted Answer

In Q2 2026, Zürcher Kantonalbank reduced its ARWR position by 4,012 shares (-8.3%).

Question 5

When did Zürcher Kantonalbank first buy ARWR?

Accepted Answer

Zürcher Kantonalbank already held ARWR in its Q1 2019 13F, the earliest on record, and has listed it in 30 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	44,360	-8.3%	$3.6M	0.0%	$81.51	0
2026-Q1	Increased	48,372	+22.9%	$3M	0.0%	$62.70	32
2025-Q4	Increased	39,365	+7.0%	$2.6M	0.0%	$66.39	28
2025-Q3	Increased	36,775	+9.7%	$1.3M	0.0%	$34.49	28
2025-Q2	Decreased	33,517	-0.2%	$529,569	0.0%	$15.80	0
2025-Q1	Decreased	33,596	-0.0%	$428,013	0.0%	$12.74	0
2024-Q4	Increased	33,606	+11.1%	$631,793	0.0%	$18.80	27
2024-Q3	Increased	30,262	+5.3%	$586,175	0.0%	$19.37	26